HFrEF - Heart Failure With Reduced Ejection Fraction Clinical Trials

6 recruiting

Frequently Asked Questions

Common questions about HFrEF - Heart Failure With Reduced Ejection Fraction clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 16 of 6 trials

Recruiting
Phase 2

Swedish Cardiac And Renal Failure Study-1

Chronic Kidney DiseaseHFrEF - Heart Failure With Reduced Ejection Fraction
Karolinska Institutet40 enrolled1 locationNCT07029503
Recruiting
Phase 2

Study of JK07 in Patients With Heart Failure and WHO Group 2 Combined Post- and Pre-Capillary Pulmonary Hypertension

HFrEF - Heart Failure With Reduced Ejection FractionHFpEF - Heart Failure With Preserved Ejection FractionGroup 2 Pulmonary Hypertension
Salubris Biotherapeutics Inc30 enrolled1 locationNCT07221513
Recruiting

Predictive Factors of Response to Phase II Cardiac Rehabilitation in Heart Failure With Reduced Ejection Fraction

Exercise TrainingHFrEF - Heart Failure With Reduced Ejection FractionCardiac Rehabilitation+3 more
Centre Hospitalier de Corbie62 enrolled1 locationNCT07164911
Recruiting

Heart Failure in Patients With Diabetes: Cells, Crosstalk and Consequences

Heart FailureDiabetes Mellitus, Type 2HFrEF - Heart Failure With Reduced Ejection Fraction+1 more
University of Leeds600 enrolled1 locationNCT06774014
Recruiting

AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor

Heart FailureCardiotoxicityMyocardial Infarction+12 more
Peerbridge Health, Inc1,500 enrolled8 locationsNCT06699056
Recruiting
Phase 1Phase 2

Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction

Heart FailureCongestive Heart FailureHFrEF - Heart Failure With Reduced Ejection Fraction+1 more
Sardocor Corp.57 enrolled5 locationsNCT04703842